会社概要
- 正式社名: CHONGQING KANGLE PHARMACEUTICAL CO.,LTD
- 登録国: China
- 住所: No. 4 Huazhong Avenue, Changshou Economic and Technological Development Zone, Chongqing 401221, China • Chongqing
- 設立年: 1988
説明:
CHONGQING KANGLE PHARMACEUTICAL CO.,LTD, established in 1988, manufactures prophylactic biological products and sells to markets across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
事業活動
医薬用化学品
製造業者
原薬(API)
原薬メーカー
バイオ医薬品
原薬メーカー
販売市場
- East Asia: Japan
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
主要製品/サービス
- 完成医薬品(製剤): Antimalarial drug substances
- 医薬用化学品: Cardiovascular APIs & intermediates, Clinical drug intermediates, Psychiatric drug intermediates, Anti-rheumatic intermediates, Anti-tumour intermediates
- バイオ医薬品: Tigecycline, Sulfadoxine, Prilocaine, Piperaquine Phosphate, Chloroquine Phosphate, Piperaquine Base, Oxiracetam, Amodiaquine Hydrochloride, Cilostazol(FDA Approved) (Micronized), Dimethicone, Ecabet Sodium, Hydroxychloroquine Sulphate
認証
US FDA
PMDA
WHO Prequalification
FDA approved
FDA
CEP証明書
DMF in Korea
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す